Dare Bioscience Inc
Change company Symbol lookup
Select an option...
DARE Dare Bioscience Inc
HEXEY Hellenic Exchanges Athens Stock Exchange SA
CLWA Fuzebox Software Corp
NGHC National General Holdings Corp
IVR Invesco Mortgage Capital Inc
CXP Columbia Property Trust Inc
TYTMF Tokyo Tatemono Co Ltd
ARPTF Airport City Ltd
KNSL Kinsale Capital Group Inc
EXLS Exlservice Holdings Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.

Closing Price
$1.28
Day's Change
0.04 (3.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.30
Day's Low
1.24
Volume
(Light)
Volume:
304,349

10-day average volume:
489,549
304,349

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.